Nathan Bahary
AHN Cancer Institute-Med Onc & Infusions at Allegheny General Hospital
Office
(412) 325-5700
Fax (412) 442-2570 314 East North Avenue, Level One Pittsburgh, PA 15212Call today!
About
Nathan Bahary
Nathan Bahary MD, PhD received his B.A. from Cornell University, an M.D. from the Cornell University School of Medicine, and his Ph.D. from the Rockefeller University. He completed his residency at Beth Israel Hospital in Boston. He did his postgraduate training at the Dana Farber Cancer Institute, Harvard, and Brigham and Women’s Hospital system before joining the faculty of UPMC as the Director of the Pancreatic Cancer Center. Since 2021, he is the Division Chief of Medical Oncology at AHN Cancer Institute and Director of AHNCI Clnical Research. Amongst his various appointments Dr. Bahary is a member of the NCI Pancreatic Task Force, the Eastern Cooperative Oncology Group (ECOG) where he serves on the ECOG GI Steering Committee and the American Society of Clinical Oncology (ASCO) His basic research interests lie in the intersection between gastrointestinal development, metabolic stress pathways, immunology, and cancer. He has a broad research background in cancer genetics, developmental biology, molecular biology, and clinical investigations, with specific training and expertise in key research areas broadly within the field of gastrointestinal oncology, and specifically within pancreatic cancer. Building on his work at Harvard Medical School, Dr. Bahary is using insights gained by studying vertebrate development to determine how cancers grow. Clinical trials emanating from this research will continue at AHN Cancer Institute and are expected to lead to the development of new targeted agents and immunologic strategies for treating cancer.
Primary Specialty
Oncologist
Practice
AHN Cancer Institute-Med Onc & Infusions at Allegheny General Hospital
Gender
Male
Education
Weill Cornell Medical College
Training
DanaFarber Cancer Institute, Beth Israel Medical Center, Beth Israel Medical Center
Certification
American Board of Internal Medicine-Medical Oncology
Not Accepting New Patients
Degrees
Medical Doctor, Doctor of Philosophy
Admitting Hospitals
Allegheny General Hospital, West Penn Hospital
Office Name
AHN Cancer Institute-Med Onc & Infusions at Allegheny General Hospital
Languages
English
Business Hours
Monday:8:00 AM - 4:00 PM
Tuesday:8:00 AM - 4:00 PM
Wednesday:8:00 AM - 4:00 PM
Thursday:8:00 AM - 4:00 PM
Friday:8:00 AM - 4:00 PM
Saturday:Closed
Sunday:Closed
Services
hepatobiliary mass, hepatic adenoma, hepatocellular carcinoma, hepatobiliary malignancies, pancreatic cancer genomics, neuroendocrine tumor of the pancreas, rectal neuroendocrine tumor, neuroendocrine tumor of duodenum, neuroendocrine tumor of the extrahepatic bile ducts, neuroendocrine tumor of the bowel, neuroendocrine tumor of the colon, neuroendocrine tumor of the gallbladder, bile duct mass, cholangiocarcinoma, anal cancer, intestinal cancer, gallbladder cancer, anal cancer chemotherapy, anal carcinoma in situ, abdominal cancer, esophageal cancer, stomach cancer, gastrointestinal (gi) cancer, colorectal malignancy, colon cancer chemotherapy, chemotherapy iv infusion, multi-cancer early detection blood test, adjuvant chemotherapy, solid tumors, advanced malignancies, systemic therapy, intravesical chemotherapy, colorectal metastases, personal history of cancer, secondary cancer screening, long term side effects of cancer treatment, personal history of radiation therapy, personal history of chemotherapy, hyperthermic intraperitoneal chemotherapy (hipec), hormone based chemotherapy, adolescent and young adult cancer (aya), intravesical therapy, carcinoma of unknown primary, targeted molecular therapy, cancer related anxiety disorder, cancer related depression, cancer related bereavement disorder, cancer related stress disorder, intrathecal chemotherapy, maintenance chemotherapy, consolidation chemotherapy, induction chemotherapy, clinical trials, intraarterial chemotherapy of tumors, occupational cancer, liver metastases, malignant carcinoid tumor of colon, cancer immunotherapy, abdominal chemotherapy, cancer related fatigue, hereditary cancer risk, reduced intensity conditioning regimens, side effects of cancer treatment, pancreas cancer, metastatic colon cancer, liver cancer, intraperitoneal hyperthermic chemoperfusion, ewings sarcoma, cancer survivor, cancer pain, cancer genomics, cancer during pregnancy, biological targeted therapy, cancer chemotherapy, cancer
Consumer Feedback
Add a Review
There are no recent reviews. Be the first!